ClinicalTrials.Veeva

Menu

Study to Identify the Reduction of Exacerbations Resulting in Hospital Admission in Patients With COPD. (BDS)

U

Universidad Autonoma de Madrid

Status

Completed

Conditions

COPD Exacerbation

Treatments

Diagnostic Test: Breath Detect Platform

Study type

Observational

Funder types

Other

Identifiers

NCT05440188
Breath Detect Study

Details and patient eligibility

About

identification of the reduction of exacerbations resulting in hospital admission in COPD patients after the use of the Breath Detect telemedicine platform.

Enrollment

80 patients

Sex

All

Ages

65+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • COPD diagnosed in GOLD II state or higher

Exclusion criteria

  • Can´t read and talk in spanish

Trial design

80 participants in 1 patient group

COPD
Description:
Patients over 65 years old diagnosed with COPD in GOLD II state or higher who uses Breath Detect Platform for monitoring their respiratory health status.
Treatment:
Diagnostic Test: Breath Detect Platform

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems